Skip to Main content Skip to Navigation
Journal articles

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03623745
Contributor : François Bertucci Connect in order to contact the contributor
Submitted on : Tuesday, March 29, 2022 - 6:58:50 PM
Last modification on : Sunday, May 1, 2022 - 3:18:01 AM

Identifiers

Citation

Patricia Pautier, Anne Floquet, Christine Chevreau, Nicolas Penel, Cécile Guillemet, et al.. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial. Lancet Oncology, Elsevier, 2015, 16 (4), pp.457-464. ⟨10.1016/s1470-2045(15)70070-7⟩. ⟨hal-03623745⟩

Share

Metrics

Record views

11